Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study

Figures

• 

  Figure 1. Study flow diagram.

• 

  Figure 2. Violin plots of the distributions of the Treatment Satisfaction Questionnaire for Medication (TSQM) satisfaction scores. Higher scores mean greater satisfaction.

• 

  Figure 3. Violin plots of the distributions of the Anti-Clot Treatment Scale (ACTS) satisfaction scores. Higher scores mean greater satisfaction.

• 

  Figure 4. Factors associated with anticoagulation satisfaction at a glance. AF, atrial fibrillation; OAC, oral anticoagulant; VKA, vitamin K antagonist.

• 

  Figure 5. Forest plots of the estimates of the effects of factors associated with satisfaction on the Treatment Satisfaction Questionnaire for Medication (TSQM II; see Supplemental Table S1 for more details). Age, Canadian Cardiovascular Society Severity of Atrial Fibrillation Scale (CCS-SAF) scale, support, and visit number were continuous variables. AF, atrial fibrillation; CHA2DS2-VASc, Congestive Heart Failure, Hypertension, Age ≥ 75 Years, Age 65 to 74 Years, Diabetes Mellitus, Stroke, Vascular Disease, Sex Category; HASBLED, Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly (> 65 Years), Drugs or Alcohol; VKA, vitamin K antagonist.

• 

  Figure 6. Forest plots of the estimates of the effects of factors associated with satisfaction on the Anti-Clot Treatment Scale (ACTS; see Supplementary Table S2 for more details). Age, Canadian Cardiovascular Society Severity of Atrial Fibrillation Scale (CCS-SAF) scale, support, and visit number were continuous variables. Refer to Table 1 for abbreviations and definitions. AF, atrial fibrillation; CHA2DS2-VASc, Congestive Heart Failure, Hypertension, Age ≥ 75 Years, Diabetes Mellitus, Stroke, Vascular Disease, Age 65 to 74 Years, Sex Category; HASBLED, Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly (> 65 Years), Drugs/Alcohol Concomitantly; VKA, vitamin K antagonist.